Tilray Brands, Inc. Restructuring Costs
Tilray Brands, Inc. (TLRY) reported Restructuring Costs of $13.11 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-07-28
- Tilray Brands, Inc. restructuring costs for the quarter ending 2026-05-31 was $7.19M, a 57.78% decline year-over-year.
- Tilray Brands, Inc. restructuring costs for the quarter ending 2026-02-28 was $4.09M, a 33.36% decline year-over-year.
- Tilray Brands, Inc. restructuring costs for the quarter ending 2025-11-30 was $965.00K, a 47.38% decline year-over-year.
- Tilray Brands, Inc. restructuring costs for the quarter ending 2025-08-31 was $869.00K, a 79.54% decline year-over-year.
- Tilray Brands, Inc. restructuring costs for fiscal 2026 was $13.11M, a 61.75% decline from fiscal 2025.
- Tilray Brands, Inc. restructuring costs for fiscal 2025 was $34.28M, a 120.03% increase from fiscal 2024.
- Tilray Brands, Inc. restructuring costs for fiscal 2024 was $15.58M, a 68.53% increase from fiscal 2023.
- Tilray Brands, Inc. restructuring costs for fiscal 2023 was $9.24M, a 1062.89% increase from fiscal 2022.
| Period end | Restructuring Costs 3 month | Restructuring Costs 3 month as first filed | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|---|
| 2026-05-31 | $7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $11.28M derived: sum of 2 quarters · filed 2026-07-28 | $12.24M derived: sum of 3 quarters · filed 2026-07-28 | $13.11M 10-K · filed 2026-07-28 | |
| 2026-02-28 | $4.09M 10-Q · filed 2026-04-01 | $5.05M derived: sum of 2 quarters · filed 2026-04-01 | $5.92M 10-Q · filed 2026-04-01 | $22.95M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-11-30 | $965.00K 10-Q · filed 2026-01-08 | $6.87M 10-Q · filed 2026-01-08 | $18.87M derived: sum of 3 quarters · filed 2026-07-28 | $25.00M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-08-31 | $869.00K 10-Q · filed 2025-10-09 | $17.90M derived: sum of 2 quarters · filed 2026-07-28 | $24.04M derived: sum of 3 quarters · filed 2026-07-28 | $25.87M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-05-31 | $17.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $23.17M derived: sum of 2 quarters · filed 2026-07-28 | $25.00M derived: sum of 3 quarters · filed 2026-07-28 | $34.28M 10-K · filed 2026-07-28 | |
| 2025-02-28 | $6.13M 10-Q · filed 2026-04-01 | $7.97M derived: sum of 2 quarters · filed 2026-04-01 | $17.25M 10-Q · filed 2026-04-01 | $19.05M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-11-30 | $1.83M 10-Q · filed 2026-01-08 | $6.87M 10-Q · filed 2025-01-10 | $11.12M 10-Q · filed 2026-01-08 | $12.91M derived: sum of 3 quarters · filed 2026-07-28 | $18.09M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $4.25M 10-Q · filed 2025-10-09 | $11.08M derived: sum of 2 quarters · filed 2026-07-28 | $16.26M derived: sum of 3 quarters · filed 2026-07-28 | $18.91M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2024-05-31 | $6.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $12.01M derived: sum of 2 quarters · filed 2026-07-28 | $14.67M derived: sum of 3 quarters · filed 2026-07-28 | $15.58M 10-K · filed 2026-07-28 | |
| 2024-02-29 | $5.18M 10-Q · filed 2025-04-08 | $7.83M derived: sum of 2 quarters · filed 2025-04-08 | $8.75M 10-Q · filed 2025-04-08 | $7.27M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-11-30 | $2.65M 10-Q · filed 2025-01-10 | $3.57M 10-Q · filed 2025-01-10 | $2.09M derived: sum of 3 quarters · filed 2025-07-29 | $4.75M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-08-31 | $915.00K 10-Q · filed 2024-10-10 | -$567.00K derived: sum of 2 quarters · filed 2025-07-29 | $2.10M derived: sum of 3 quarters · filed 2025-07-29 | $10.16M derived: sum of 4 quarters · filed 2025-07-29 | |
| 2023-05-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $1.18M derived: sum of 2 quarters · filed 2025-07-29 | $9.24M derived: sum of 3 quarters · filed 2025-07-29 | $9.24M 10-K · filed 2025-07-29 | |
| 2023-02-28 | $2.66M 10-Q · filed 2024-04-09 | $10.73M derived: sum of 2 quarters · filed 2024-04-09 | $10.73M 10-Q · filed 2024-04-09 | ||
| 2022-11-30 | $8.06M 10-Q · filed 2024-01-09 | $8.06M 10-Q · filed 2024-01-09 | |||
| 2022-05-31 | $795.00K 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |